Vanguard Group
KRSA

Vanguard Group’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Vanguard Group’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$29.8K Hold
3,356
– – ﹤0.01% 4289
2025
Q3 		$54K Hold
3,356
– – ﹤0.01% 4293
2025
Q2 		$68.4K Hold
3,356
– – ﹤0.01% 4170
2025
Q1 		$58K Hold
3,356
– – ﹤0.01% 4184
2024
Q4 		$75.6K Hold
3,356
– – ﹤0.01% 4185
2024
Q3 		$60.6K Hold
3,356
– – ﹤0.01% 4235
2024
Q2 		$54K Hold
3,356
– – ﹤0.01% 4285
2024
Q1 		$75.2K Hold
3,356
– – ﹤0.01% 4266
2023
Q4 		$78.7K Sell
3,356
-2,434
-42% -$7.04K ﹤0.01% 4325
2023
Q3 		$139K Sell
5,790
-5,806
-50% -$20.9K ﹤0.01% 4308
2023
Q2 		$334K Sell
11,596
-201
-2% -$1.04K ﹤0.01% 4218
2023
Q1 		$717K Hold
11,797
– – ﹤0.01% 4011
2022
Q4 		$1.08M Buy
11,797
+6
+0.1% +$71 ﹤0.01% 3884
2022
Q3 		$1.42M Sell
11,791
-739
-6% -$12.7K ﹤0.01% 3879
2022
Q2 		$963K Hold
12,530
– – ﹤0.01% 4102
2022
Q1 		$1.95M Sell
12,530
-830
-6% -$20K ﹤0.01% 3969
2021
Q4 		$3.22M Buy
13,360
+3,131
+31% +$148K ﹤0.01% 3847
2021
Q3 		$4.4M Buy
10,229
+61
+0.6% +$3.99K ﹤0.01% 3743
2021
Q2 		$5.55M Sell
10,168
-1,754
-15% -$110K ﹤0.01% 3538
2021
Q1 		$4.66M Buy
11,922
+28
+0.2% +$2.1K ﹤0.01% 3568
2020
Q4 		$5.09M Sell
11,894
-388
-3% -$26.5K ﹤0.01% 3345
2020
Q3 		$10.5M Buy
12,282
+4,271
+53% +$488K ﹤0.01% 2760
2020
Q2 		$6.63M Sell
8,011
-1,223
-13% -$102K ﹤0.01% 2963
2020
Q1 		$3.42M Buy
9,234
+8
+0.1% +$571 ﹤0.01% 3132
2019
Q4 		$3.51M Sell
9,226
-25
-0.3% -$2.33K ﹤0.01% 3284
2019
Q3 		$15.7M Buy
9,251
+1,249
+16% +$270K ﹤0.01% 2592
2019
Q2 		$12.8M Buy
+8,002
New +$2.26M ﹤0.01% 2716

Other funds holding KRSA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group's KRSA Position: Q4 2025 in Review

Vanguard Group held its Korsana Biosciences, Inc. Common Stock (KRSA) position steady in Q4 2025 at 3,356 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4289.

Vanguard Group first reported a position in KRSA in Q2 2019 and has held it in 27 quarters since. The position peaked at $15.7M in Q3 2019. 18 funds tracked by Wall St. Rank hold KRSA as of Q4 2025.

  • Vanguard Group held 3,356 shares of Korsana Biosciences, Inc. Common Stock worth $29.8K as of Q4 2025.
  • Vanguard Group left its Korsana Biosciences, Inc. Common Stock share count unchanged in Q4 2025.
  • Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4289 holding.
  • Vanguard Group first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 27 quarters since.
  • Vanguard Group's Korsana Biosciences, Inc. Common Stock position peaked at $15.7M in Q3 2019.
  • 18 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.